|
A.A. Plotnikova, L.Yu. Milovanova, Yu.S. Milovanov
Paricalcitol – new opportunities in nephroprotection and treatment of secondary hyperparathyreosis
|
№4 / 2012
|
|
A.N. Fedoseev, A.S. Kudriakova, V.V. Smirnov, T.A. Krutova, K.V. Ovsiannikov
Ace inhibitors in endothelial dysfunction correction in patients with c chronic kidney disease
|
№4 / 2012
|
|
O.N. Kurochkina
Determination of renal function with glomerular filtration rate parameter in ambulatory practice
|
№4 / 2012
|
|
M.M. Batiushin, A.A. Gaushkin, V.N. Poganeva, E.G. Asrumian, A.S. Litvinov, N.A. Sadovnichaya, D.S. Tsevtskov, L.I. Rudenko
Sulodexide (“Vessel Due F”) – new perspectives in nephroprotecive therapy
|
№3 / 2012
|
|
N.A. Mukhin, L.A. Alekseeva, V.S. Babanin, E.D. Dokina, L.O. Minushkina
Renal function and heart valve calcification in postmenopausal women
|
№3 / 2012
|
|
V.V. Kaliuzhin, O.F. Sibirtseva, O.I. Urazova, E.V. Kaliuzhina, L.M. Tkalich, Li.I. Zibnitskaya, R.N. Kolesnikov, V.Yu. Grankina
Laboratory markers of haemosthasis panel in prognosing of progression of chronic kidney disease
|
№3 / 2012
|
|
A.P. Rebrov, O.G. Kargalskaya
Prevalence of chronic kidney disease in patients with psoriatic arthritis
|
№3 / 2012
|
|
Yu.A. Pigareva, S.V. Avdoshina, T.B. Dmitrova, M.A. Efremovtseva, Zh.G. Tigay
Prevalence of chronic kidney disease in patients of clinic of internal diseases
|
№3 / 2012
|
|
E.M. Shilov, E.I. Levankovskaya, M.S. Novikova
New approaches in treatment of chronic kidney disease in metabolic syndrome
|
№2 / 2012
|
|
T.E. Rudenko, I.M. Kutyrina, M.Yu. Shvetsov
Lipid metabolism in chronic kidney disease
|
№2 / 2012
|
|
N.A. Moukhin
Difficult nephrological patient today
|
№2 / 2012
|
|
M.S. Molchanova, E.E. Tikhomirov, L.P. Bykova, E.A. Molchanova, A.L. Rumiantsev, A.L. Valov, D.B. Ektov, V.A. Gavrilova, Yu.B. Yurasova, E.K. Petrosian
Role of R990G polymorphism of calcium-sensing receptor gene in regulation of parathyroid hormone level in children with chronic kidney disease stage II–V
|
№1 / 2012
|
Русский
